SOURCE: Micro Imaging Technology, Inc.

August 04, 2008 08:00 ET

MIT 1000 System Receives Excellent Independent Evaluation Results

SAN CLEMENTE, CA--(Marketwire - August 4, 2008) - Micro Imaging Technology, Inc. (OTCBB: MMTC) announces that its product, the MIT 1000 Rapid Microbial Identification System, has received additional test results from two independent evaluators. Recently, the Company announced that the USDA's chief scientific center, Agricultural Research Service, and Pacific Coast Analytical Services (PCAS), a full service testing laboratory, are evaluating the MIT 1000 system for the detection and identification of the most widespread food pathogens; including Listeria, E.coli, and Salmonella.

The MIT 1000 is being compared with conventional testing processes and evaluated for identification accuracy, speed, and test costs. The evaluation protocol required that the MIT System be tasked with correctly identifying the Listeria bacteria and correctly identifying other organisms as not Listeria. The latter is to test the System's vulnerability for false positive results.

The combined results after 115 Listeria confirmation tests and 153 false positive tests conducted were: The MIT 1000 recorded a perfect 100% score for the confirmation tests and had only 13 false positive that were all attributed to the misidentification of only one bacterial species, Aeromonas hydrophila as Listeria.

"We are delighted with the results received by both organizations. While the false positive results were higher than we would like, they are competitive with other bacteria identification systems. Also, given that the false positives were isolated to one specie only, adding it to our database will eliminate future false positives for that species," stated Michael Brennan, MIT's Chairman. "The continued feedback by our evaluators enables us to make further improvements to the System which was one of the main objectives of these evaluations," stated John Ricardi, MIT's VP of Business Development.

About Micro Imaging Technology

The Company has developed and patented a technology for rapid microbe detection and identification. This System measures scattered light intensity as individual microbes pass through a laser beam. The intensity pattern of the scattered light is a direct consequence of the size, shape and external and internal optical characteristics of the microbe. The MIT System is totally GREEN, is non-biological, and does not rely on biological agents, conventional chemical processing, fluorescent tags, gas chromatography or DNA analysis -- uses only clean water as a test medium.

MIT has demonstrated the ability to detect and identify, within several minutes, the microbes Escherichia coli, Listeria, Salmonella, Staphylococcus aureus, and other pathogenic bacteria. MIT recently performed over 300 tests for the identification of the aforementioned contaminants and scored 95% accuracy. The System can currently identify 23 species of bacteria and is easily expandable. The identification process has been verified by North American Science Associates, Inc. (NAMSA), an independent, internationally recognized biological testing laboratory. The NAMSA Test Report compiled from their own tests, in the Company's opinion, demonstrated the accuracy, speed and efficiency of the MIT System over conventional processes and is available from the Company. The Company is in the process of completing another independently designed evaluation test; conducted by the Association of Analytic Communities (AOAC).

This release contains statements that are forward-looking in nature. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements. These statements are made based upon information available to the Company as of the date of this release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time within our filings with the Securities and Exchange Commission.

Contact Information

  • CONTACT:
    Michael Brennan, Chairman
    Email: Email Contact
    Telephone: (805) 557-0614